Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail J Roboz

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
Blood|October 7, 2024
How I use maintenance therapy in acute myeloid leukemiaGail J Roboz, Jonathan Canaani
Expert Review of Hematology|February 27, 2015
Mass spectrometry in leukemia research and treatmentJohn Roboz, Gail J Roboz
Current Hematologic Malignancy Reports|November 2, 2013
Standardizing the initial evaluation for myelodysplastic syndromesDanielle Marshall, Gail J Roboz
Expert Opinion on Drug Discovery|September 24, 2016
The application of mass spectrometry to leukemia drug discoveryGail J Roboz, John Roboz
Current Hematologic Malignancy Reports|April 29, 2010
Levels of care: defining best supportive care in elderly patients with acute myeloid leukemiaEllen K Ritchie, Gail J Roboz
Current Hematology Reports|October 17, 2003
Hematopoietic growth factors in myelodysplastic syndromesVictoria S Blinder, Gail J Roboz
Best Practice & Research. Clinical Haematology|June 18, 2019
Clonal Hematopoiesis and risk of Acute Myeloid LeukemiaPinkal Desai, Duane Hassane, Gail J Roboz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute LeukemiaJohn P Leonard, Peter Martin, Gail J Roboz
The New England Journal of Medicine|March 31, 2021
Oral Azacitidine Maintenance for Acute Myeloid Leukemia. ReplyAndrew H Wei, Hartmut Döhner, Gail J Roboz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid LeukemiaAndrew H Wei, Gail J Roboz, Hagop M Kantarjian
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
Blood|October 7, 2024
How I use maintenance therapy in acute myeloid leukemiaGail J Roboz, Jonathan Canaani
Expert Review of Hematology|February 27, 2015
Mass spectrometry in leukemia research and treatmentJohn Roboz, Gail J Roboz
Current Hematologic Malignancy Reports|November 2, 2013
Standardizing the initial evaluation for myelodysplastic syndromesDanielle Marshall, Gail J Roboz
Expert Opinion on Drug Discovery|September 24, 2016
The application of mass spectrometry to leukemia drug discoveryGail J Roboz, John Roboz
Current Hematologic Malignancy Reports|April 29, 2010
Levels of care: defining best supportive care in elderly patients with acute myeloid leukemiaEllen K Ritchie, Gail J Roboz
Current Hematology Reports|October 17, 2003
Hematopoietic growth factors in myelodysplastic syndromesVictoria S Blinder, Gail J Roboz
Best Practice & Research. Clinical Haematology|June 18, 2019
Clonal Hematopoiesis and risk of Acute Myeloid LeukemiaPinkal Desai, Duane Hassane, Gail J Roboz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute LeukemiaJohn P Leonard, Peter Martin, Gail J Roboz
The New England Journal of Medicine|March 31, 2021
Oral Azacitidine Maintenance for Acute Myeloid Leukemia. ReplyAndrew H Wei, Hartmut Döhner, Gail J Roboz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid LeukemiaAndrew H Wei, Gail J Roboz, Hagop M Kantarjian
Pageof 21